First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study

BACKGROUND: The nadir value of the absolute neutrophil count (ANC) in the first cycle of chemotherapy is an effective predictor of subsequent neutropenic events. This study was designed to validate an earlier published study based on a retrospective data analysis from a prospective randomized clinic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rivera, Edgardo, Haim Erder, M, Fridman, Moshe, Frye, Debra, Hortobagyi, Gabriel N
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC314422/
https://ncbi.nlm.nih.gov/pubmed/12927041
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares